Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2016, Article ID 8102478, 11 pages
http://dx.doi.org/10.1155/2016/8102478
Research Article

Therapeutic Potential of Dental Pulp Stem Cell Secretome for Alzheimer’s Disease Treatment: An In Vitro Study

1Department of Stem Cell Biology and Regenerative Medicine, National Center for Geriatrics and Gerontology, Research Institute, Obu, Aichi 474-8511, Japan
2Department of Orodental Genetics, Division of Human Genetics and Human Genome, National Research Center, Cairo 12311, Egypt
3Department of Oral and Molecular Microbiology, Osaka University Graduate School of Dentistry, Osaka 565-0871, Japan

Received 14 December 2015; Revised 25 April 2016; Accepted 16 May 2016

Academic Editor: Pavla Jendelova

Copyright © 2016 Nermeen El-Moataz Bellah Ahmed et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Li, K. Guo, and S. Ikehara, “Stem cell treatment for Alzheimer’s disease,” International Journal of Molecular Sciences, vol. 15, no. 10, pp. 19226–19238, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. Alzheimer's Association, “Alzheimer's disease facts and figures,” Alzheimer's & Dementia, vol. 9, no. 2, pp. 208–245, 2013. View at Publisher · View at Google Scholar
  3. A.-S. Carret-Rebillat, C. Pace, S. Gourmaud et al., “Neuroinflammation and Aβ accumulation linked to systemic inflammation are decreased by genetic PKR down-regulation,” Scientific Reports, vol. 5, article 8489, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. T. C. B. Piermartiri, C. P. Figueiredo, D. Rial et al., “Atorvastatin prevents hippocampal cell death, neuroinflammation and oxidative stress following amyloid-β1 − 40 administration in mice: evidence for dissociation between cognitive deficits and neuronal damage,” Experimental Neurology, vol. 226, no. 2, pp. 274–284, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. W.-W. Zhou, S. Lu, Y.-J. Su et al., “Decreasing oxidative stress and neuroinflammation with a multifunctional peptide rescues memory deficits in mice with Alzheimer disease,” Free Radical Biology and Medicine, vol. 74, pp. 50–63, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Ma, K. Gong, Q. Ao et al., “Intracerebral transplantation of adipose-derived mesenchymal stem cells alternatively activates microglia and ameliorates neuropathological deficits in Alzheimer's disease mice,” Cell Transplantation, vol. 22, no. 1, pp. S113–S126, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Y. Shin, H. J. Park, H. N. Kim et al., “Mesenchymal stem cells enhance autophagy and increase β-amyloid clearance in Alzheimer disease models,” Autophagy, vol. 10, no. 1, pp. 32–44, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Yan, T. Ma, K. Gong, Q. Ao, X. Zhang, and Y. Gong, “Adipose-derived mesenchymal stem cell transplantation promotes adult neurogenesis in the brains of Alzheimer's disease mice,” Neural Regeneration Research, vol. 9, no. 8, pp. 798–805, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. J.-S. Bae, H. K. Jin, J. K. Lee, J. C. Richardson, and J. E. Carter, “Bone marrow-derived mesenchymal stem cells contribute to the reduction of amyloid-β deposits and the improvement of synaptic transmission in a mouse model of pre-dementia Alzheimer's disease,” Current Alzheimer Research, vol. 10, no. 5, pp. 524–531, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Crigler, R. C. Robey, A. Asawachaicharn, D. Gaupp, and D. G. Phinney, “Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis,” Experimental Neurology, vol. 198, no. 1, pp. 54–64, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Biancone, S. Bruno, M. C. Deregibus, C. Tetta, and G. Camussi, “Therapeutic potential of mesenchymal stem cell-derived microvesicles,” Nephrology Dialysis Transplantation, vol. 27, no. 8, pp. 3037–3042, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Katsuda, R. Tsuchiya, N. Kosaka et al., “Human adipose tissue-derived mesenchymal stem cells secrete functional neprilysin-bound exosomes,” Scientific Reports, vol. 3, article 1197, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Paul and S. V. Anisimov, “The secretome of mesenchymal stem cells: potential implications for neuroregeneration,” Biochimie, vol. 95, no. 12, pp. 2246–2256, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. E. Karaöz, P. C. Demircan, Ö. Saflam, A. Aksoy, F. Kaymaz, and G. Duruksu, “Human dental pulp stem cells demonstrate better neural and epithelial stem cell properties than bone marrow-derived mesenchymal stem cells,” Histochemistry and Cell Biology, vol. 136, no. 4, pp. 455–473, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. I. Kerkis, A. Kerkis, D. Dozortsev et al., “Isolation and characterization of a population of immature dental pulp stem cells expressing OCT-4 and other embryonic stem cell markers,” Cells Tissues Organs, vol. 184, no. 3-4, pp. 105–116, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. B. Mead, A. Logan, M. Berry, W. Leadbeater, and B. A. Scheven, “Paracrine-mediated neuroprotection and neuritogenesis of axotomised retinal ganglion cells by human dental pulp stem cells: comparison with human bone marrow and adipose-derived mesenchymal stem cells,” PLoS ONE, vol. 9, no. 10, Article ID e109305, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Sakai, A. Yamamoto, K. Matsubara et al., “Human dental pulp-derived stem cells promote locomotor recovery after complete transection of the rat spinal cord by multiple neuro-regenerative mechanisms,” The Journal of Clinical Investigation, vol. 122, no. 1, pp. 80–90, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. F. M. De Almeida, S. A. Marques, B. D. S. Ramalho et al., “Human dental pulp cells: a new source of cell therapy in a mouse model of compressive spinal cord injury,” Journal of Neurotrauma, vol. 28, no. 9, pp. 1939–1949, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Apel, O. V. Forlenza, V. J. R. De Paula et al., “The neuroprotective effect of dental pulp cells in models of Alzheimer's and Parkinson's disease,” Journal of Neural Transmission, vol. 116, no. 1, pp. 71–78, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. D. Tripathy, L. Thirumangalakudi, and P. Grammas, “RANTES upregulation in the Alzheimer's disease brain: a possible neuroprotective role,” Neurobiology of Aging, vol. 31, no. 1, pp. 8–16, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Religa, R. Cao, D. Religa et al., “VEGF significantly restores impaired memory behavior in Alzheimer's mice by improvement of vascular survival,” Scientific Reports, vol. 3, article 2053, 2013. View at Google Scholar · View at Scopus
  22. B. D. Semple, N. Bye, M. Rancan, J. M. Ziebell, and M. C. Morganti-Kossmann, “Role of CCL2 (MCP-1) in traumatic brain injury (TBI): evidence from severe TBI patients and CCL2−/− mice,” Journal of Cerebral Blood Flow & Metabolism, vol. 30, no. 4, pp. 769–782, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. S.-H. Cho, B. Sun, Y. Zhou et al., “CX3CR1 protein signaling modulates microglial activation and protects against plaque-independent cognitive deficits in a mouse model of Alzheimer disease,” Journal of Biological Chemistry, vol. 286, no. 37, pp. 32713–32722, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. C. A. DeBoy, H. Rus, C. Tegla et al., “FLT-3 expression and function on microglia in multiple sclerosis,” Experimental and Molecular Pathology, vol. 89, no. 2, pp. 109–116, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. T. D. Boyd, S. P. Bennett, T. Mori et al., “GM-CSF upregulated in rheumatoid arthritis reverses cognitive impairment and amyloidosis in Alzheimer mice,” Journal of Alzheimer's Disease, vol. 21, no. 2, pp. 507–518, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Uccelli, A. Laroni, and M. S. Freedman, “Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases,” The Lancet Neurology, vol. 10, no. 7, pp. 649–656, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. F. G. Teixeira, M. M. Carvalho, A. Neves-Carvalho et al., “Secretome of mesenchymal progenitors from the umbilical cord acts as modulator of neural/glial proliferation and differentiation,” Stem Cell Reviews and Reports, vol. 11, no. 2, pp. 288–297, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. I. V. Nosrat, C. A. Smith, P. Mullally, L. Olson, and C. A. Nosrat, “Dental pulp cells provide neurotrophic support for dopaminergic neurons and differentiate into neurons in vitro; implications for tissue engineering and repair in the nervous system,” European Journal of Neuroscience, vol. 19, no. 9, pp. 2388–2398, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. B. A. Yankner, “Mechanisms of neuronal degeneration in Alzheimer's disease,” Neuron, vol. 16, no. 5, pp. 921–932, 1996. View at Publisher · View at Google Scholar · View at Scopus
  30. M. P. Mattson, “Neuronal life-and-death signaling, apoptosis, and neurodegenerative disorders,” Antioxidants & Redox Signaling, vol. 8, no. 11-12, pp. 1997–2006, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. E. Paradis, H. Douillard, M. Koutroumanis, C. Goodyer, and A. LeBlanc, “Amyloid beta peptide of Alzheimer's disease downregulates Bcl-2 and upregulates Bax expression in human neurons,” The Journal of Neuroscience, vol. 16, no. 23, pp. 7533–7539, 1996. View at Google Scholar · View at Scopus
  32. M. P. Mattson, “Apoptosis in neurodegenerative disorders,” Nature Reviews Molecular Cell Biology, vol. 1, no. 2, pp. 120–129, 2000. View at Publisher · View at Google Scholar · View at Scopus
  33. E. Pérez-Navarro, N. Gavaldà, E. Gratacòs, and J. Alberch, “Brain-derived neurotrophic factor prevents changes in Bcl-2 family members and caspase-3 activation induced by excitotoxicity in the striatum,” Journal of Neurochemistry, vol. 92, no. 3, pp. 678–691, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. H.-R. Kim, Y.-M. Heo, K.-I. Jeong et al., “FGF-2 inhibits TNF-α mediated apoptosis through upregulation of Bcl2-A1 and Bcl-xL in ATDC5 cells,” BMB Reports, vol. 45, no. 5, pp. 287–292, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. E. A. Beierle, L. F. Strande, and M. K. Chen, “VEGF upregulates BCL-2 expression and is associated with decreased apoptosis in neuroblastoma cells,” Journal of Pediatric Surgery, vol. 37, no. 3, pp. 467–471, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. E. H. Yi, C. S. Lee, J.-K. Lee et al., “STAT3-RANTES autocrine signaling is essential for tamoxifen resistance in human breast cancer cells,” Molecular Cancer Research, vol. 11, no. 1, pp. 31–42, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. S. A. Boehme, F. M. Lio, D. Maciejewski-Lenoir, K. B. Bacon, and P. J. Conlon, “The chemokine fractalkine inhibits Fas-mediated cell death of brain microglia,” Journal of Immunology, vol. 165, no. 1, pp. 397–403, 2000. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Wang, R. Wang, L. Chen, D. A. Bennett, D. W. Dickson, and D.-S. Wang, “Expression and functional profiling of neprilysin, insulin-degrading enzyme, and endothelin-converting enzyme in prospectively studied elderly and Alzheimer's brain,” Journal of Neurochemistry, vol. 115, no. 1, pp. 47–57, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. P. Szabo, N. Relkin, and M. E. Weksler, “Natural human antibodies to amyloid beta peptide,” Autoimmunity Reviews, vol. 7, no. 6, pp. 415–420, 2008. View at Publisher · View at Google Scholar · View at Scopus